July 5th, 2022

Our very own Rachel Weathered gives a fascinating look into her work and her mission deciphering the secrets of cancer immunology and developing new tools, to help stem the tide against one of the worst and most wide spread diseases of our times. 

"Rachel Weathered, PhD’22, applies her scientific expertise to investment strategy, guiding financial firms through one of medicine’s most promising new fields."

Read more about Rachels story at PME NEWS


July, 2022

Thanks to our PostDoc Anish Mukerjee, our special journal club for undergatuate and summer students

is up and running. 

Here you will learn how to read a paper and understand what it means in a greater scientific context. 

Also it's a ton of fun, contact Anish for more information. 

December 23rd, 2021

The famous Big Brains podcast talked to our own Profs. Swartz and Hubbell. 

A wonderfully easy way to learn, who we are, 

what we do and why we do it in our PIs words. 

Have fun and a happy New Year from all of us!

On Air Sign
Radio Show

March 24th, 2021

PME featuring our latest Science Advances paper.

"Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas"

A collaborative effort together with the Hubbell group, our study introduces the potential of lymphangiogenesis induction as a novel immunotherapeutic strategy to consider in cancer vaccine design.


For the whole story please go to


Melody Swartz.jpg

October 19th, 2020

Melody Swartz elected to

the National Academy of Medicine

Our very own Melody Swartz has been elected to the National Academy of Medicine.

The good news is featured by the Pritzker School of Molecular Engineering and online:


June 22nd-24th 2020

AACR 2020

It is good to check in with our collaborators around the globe at the annual meeting of the  American Association for Cancer Research. ​

Due to Covid19 this years meeting is virtual and registration is free.


Getting a closer look at our latest work has never been easier.

Watch a presentation by Melody Swartz

on June 24, 2020 at 2:15 PM U.S. EDT,

Session MW12 - Emerging Models: Bring in the Engineers


"In vitro models of the tumor-immune interface".





AACR 2020

Our very own Nick, Maria Stella and Peyman have presented their latest findings at AACR online.

For more information click on their abstracts.


Immune Mechanisms Invoked by Therapies 2

June 22, 2020, 9:00 AM - 6:00 PM

2253 / 6 - Lymphangiogenesis augments the anti-tumor efficacy of radiotherapy in mouse melanoma

By Nick Mitrousis



Immunomodulatory Agents and Interventions

June 23, 2020, 9:20 AM - 9:30 AM

1072 - Lymphangiogenesis-inducing vaccines for melanoma treatment elicit potent tumor-specific T cell immunity and long-term tumor control


By Maria Stella Sasso



Novel Immunotherapies and Mechanisms

June 23, 2020, 9:20 AM - 9:30

5695  Induction of lymphangiogenesis in breast cancer enhances responsiveness to immunotherapies

By Peyman Hosseinchi


June 12th, 2020

CIIC featuring our latest nature paper.

A collaborative effort together with the Sperling group, our study investigates the role of pro-lymphangiogenic VEGFR-3 signaling in allergic airway inflammation.


For the whole story please go to


May 26th, 2020

Chicago Maroon discusses PME Covid Resesearch

Research at the CIIC includes cancer immunotherapy and therapies for fruit allergies. But recently, the CIIC has focused a large effort toward COVID-19 research. Currently, there are projects for creating a vaccine for the disease led by Jeffrey Hubbell and Melody Swartz, co-directors of the center.

“The vaccine projects harmoniously bring together the resources of Pritzker School of Molecular Engineering and medical centers across the country,” Hubbell said.

To read the article please follow the link below.


Screen Shot 2020-05-28 at 9.38.37 AM.png

April 24th, 2020

Congratulations to our Nick Mitrousis, PhD.


Nick's innovative work on exploring the role of lymphangiogenesis

in the anti-tumor immune response to radiotherapy

is being supported by the CIHR's postdoctoral fellowship.